News

We’re thrilled to announce that ChAbS  LinkedIn page has officially surpassed 20,000 followers ! This milestone reflects the growing global community that shares our mission — to connect industry, academia, and investment and advance innovation in antibody therapeutics. A heartfelt thank you to all our members, partners, and supporters for being part of this journey. Your engagement inspires us to keep building a stronger platform for collaboration and knowledge exchange. Fol

We are excited to announce that the Chinese Antibody Society (CAS) has officially updated its identity. The organization’s new abbreviation is ChAbs, and with it comes a refreshed logo that better reflects our mission and vision. This change marks an important step in strengthening our community presence and advancing antibody research together.

ChAbS is proud to announce the launch of its newly designed website, created to better serve our members and the broader scientific...

Antibody Therapeutics, published by Oxford University Press, is proud to announce the award of its inaugural Impact Factor of 4.5 by Clarivate Analytics in the latest Journal Citation Report (JCR). This milestone highlights the journal’s growing influence and its dedication to advancing high-quality research in antibody engineering and antibody-based therapies. We extend our sincere gratitude to our authors, readers, reviewers, editors, and editorial board members, as we